Internal Medicine, Nephrology · Clarksdale, MS
NPI
1760654990
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
785 Ohio Ave, Suite 2h
Clarksdale, MS, 38614
Phone (662) 627-3003
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
1,579 services
Medicare patients, 2024
380
Average age 70
Drug cost, 2024
$1.3M
3,560 prescriptions
Company payments, 2025
$383
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vikram R Beemidi was code 90960 (esrd related services (not dialysis)), 340 times for 42 patients. In total Vikram R Beemidi billed 1,579 services in 17 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 340 | 42 | $260.67 | $89K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 247 | 140 | $11.58 | $2,861 |
| 99214 Office E&M - Established | Office | 220 | 118 | $82.93 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 180 | 95 | $59.76 | $11K |
| 90935 Hemodialysis | Facility | 132 | 76 | $53.57 | $7,071 |
| 99233 Hospital E&M - Subsequent | Facility | 117 | 61 | $87.91 | $10K |
| 99223 Hospital E&M - Initial | Facility | 69 | 67 | $126.53 | $8,731 |
| 99222 Hospital E&M - Initial | Facility | 63 | 47 | $94.11 | $5,929 |
| 90961 ESRD Related Services (not dialysis) | Office | 52 | 20 | $215.67 | $11K |
| 99213 Office E&M - Established | Office | 29 | 25 | $42.01 | $1,218 |
| 99204 Office E&M - New | Office | 21 | 21 | $98.73 | $2,073 |
By year: 2022 $144K for 1,191 services; 2023 $162K for 1,238 services; 2024 $182K for 1,579 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vikram R Beemidi prescribed most often to Medicare patients was Amlodipine Besylate, with 286 prescriptions and refills. In total Vikram R Beemidi wrote 3,560 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 286 | 672 | 94 | $1,350 |
| Velphoro Sucroferric Oxyhydroxide | 246 | 280 | 37 | $780K |
| Olmesartan Medoxomil Generic | 243 | 553 | 86 | $2,336 |
| Sevelamer Carbonate Generic | 239 | 303 | 44 | $26K |
| Calcitriol Generic | 188 | 398 | 52 | $2,712 |
| Hydralazine Hcl Generic | 174 | 387 | 62 | $2,197 |
| Furosemide Generic | 173 | 384 | 55 | $912 |
| Carvedilol Generic | 170 | 411 | 62 | $1,206 |
| Losartan Potassium Generic | 158 | 345 | 49 | $1,189 |
| Potassium Chloride Generic | 151 | 330 | 63 | $1,548 |
| Nifedipine Er Nifedipine | 122 | 293 | 42 | $2,088 |
| Allopurinol Generic | 108 | 277 | 38 | $944 |
| Kerendia Finerenone | 108 | 194 | 28 | $120K |
| Farxiga Dapagliflozin Propanediol | 91 | 125 | 19 | $68K |
| Spironolactone Generic | 91 | 231 | 34 | $726 |
Brand drugs: 686 claims; generic drugs: 2,874 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vikram R Beemidi $383 ($383 in general payments such as food, travel and fees) from 9 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $108.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $108 |
| Vifor Pharma, Inc. | 4 | $71.75 |
| Fresenius USA Marketing, Inc. | 2 | $41.2 |
| Travere Therapeutics, Inc. TVTX | 1 | $37.2 |
| Ardelyx, Inc. ARDX | 2 | $32.64 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $28.48 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $25.16 |
| Calliditas Therapeutics US Inc. | 1 | $22.91 |
| Idorsia Pharmaceuticals US Inc | 1 | $16.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.